Revised 5/31/2014 May 31, 2014 CURRICULUM VITAE KIMBERLY J

Revised 5/31/2014 May 31, 2014 CURRICULUM VITAE KIMBERLY J. PEREZ, MD

Rhode Island Hospital Division of Hematology/Oncology 593 Eddy Street Providence, RI 02903 Business Telephone 401-444-4538 Business Fax 401-444-8918 E-Mail [email protected] EDUCATION 1994-1995 New York University New York, NY

1995-1999 Georgetown University Washington, D.C. Bachelor of Arts, History

1999-2001 St. George’s University School of Medicine Grenada, West Indies Medical Doctorate

2001-2004 George Washington University School of Medicine Washington, D.C. Medical Doctorate

POST GRADUATE TRAINING 2004-2007 Resident in Internal Medicine Internal Medicine Residency Program, Rhode Island Hospital, Miriam Hospital Alpert Medical School of Brown University Providence, RI

2007- 2010 Fellow in Hematology and Oncology Hematology-Oncology Fellowship, Rhode Island Hospital, Miriam Hospital Alpert Medical School of Brown University Providence, RI

2013 Attendee/ Alumni Intensive Course in Cancer Risk Assessment

1 City of Hope Duarte, California

HONORS AND AWARDS 1994-1995 Dean’s List, New York University 1998 Dean’s List, Georgetown University 1999-2000 Dean’s List, St. George’s University School of Medicine 1999 Chancellor’s List, St. George’s University School of Medicine 1999-2001 Member, Iota Epsilon Alpha (IEA) Honor Society, St. George’s University School of Medicine. 2000 IEA Office of Marshall 2010, 2011 Certificate of Recognition for Exemplary Teaching, BioMed: Pathophysiology, BIOL3672IMSIV: Hematology Section, The Warren Alpert Medical School of Brown University

MILITARY SERVICE NA PROFESSIONAL LICENSES AND BOARD CERTIFICATIONS Certification: 2007 - Diplomate, American Board of Internal Medicine

2011 - Diplomate, Hematology American Board of Internal Medicine

2011 - Diplomate, Oncology American Board of Internal Medicine

Licensure: 2010 – State Of Rhode Island

ACADEMIC APPOINTMENTS

2010 Assistant Professor. Department of Internal Medicine; Division of Hematology Oncology Warren Alpert School of Medicine of Brown University Providence, RI 02906

HOSPITAL APPOINTMENTS

2010 Attending Physician Rhode Island Hospital Department of Internal Medicine; Division of Hematology Oncology 593 Eddy Street Providence RI 02903

2010 Attending Physician The Miriam Hospital Department of Internal Medicine; Division of Hematology Oncology 164 Summit Avenue; Providence, RI 02906

2010 - 2012 Adult Hematologist Rhode Island Hemostasis and Thrombosis Center, Department of Pediatrics, Division of Hematology Oncology Rhode Island Hospital, 593 Eddy Street Providence RI 02903

2012 Adult Oncologist Cancer Genetics Program, Department of Pediatrics, Division of Genetics Rhode Island Hospital, 593 Eddy Street Providence RI 02903

MEMBERSHIP IN SOCIETIES

2004 American College of Physicians

2006 American Medical Association

2007 American Society of Hematology

2007 American Society of Clinical Oncology

2010 Radiation Therapy Oncology Group (RTOG) • Gastrointestinal Oncology Committee Member • Medical Oncology Committee Member

2010 Brown University Oncology Group • Gastrointestinal Oncology Committee Leader • DSMB committee member

2012 Gastrointestinal Stromal Tumor Working Group (GIST WG) of the National Cancer Institute’s Gastrointestinal Steering Committee (GISC) • NCIC CTG representative

2014 NRG Oncology • Gastrointestinal Oncology Committee Member o Noncolorectal subcommittee multidisciplinary representative

3 • Medical Oncology Committee Member

PUBLICATIONS LIST ORIGINAL PUBLICATIONS IN PEER REVIEWED JOURNALS* 1. Perez K, Gopalakrishnan G, Misra B, Malone C, Tupper T. Big head disease. J Gen Intern Med 2006; 21[suppl 4]: 225-226. 2. Duffy C, Perez K, Partidge A. Implications of Phytoestrogen Intake for Breast Cancer. CA: Cancer Journal for Clinicians. September 1, 2007; 57:260-277. 3. Dizon DS, Perez K, DiSilvestro P, Taneja C, Ilson D. Stage IV small bowel carcinoma mimicking advanced ovarian cancer: case report and review of the literature. American Surgeon. 2009 Sep;75(9):864-5. 4. Perez K, Gadgil M, and Dizon DS. Sexual ramifications of medical illness. Clinics of Obstetrics and Gynecology December 2009; Volume 52, Number 4, 691–701. 5. Castillo J, Perez K, Milani C, Pantanowitz L, Dezube B. Peripheral T- cell lymphoma in HIV-infected individuals: A comprehensive review. Journal of HIV Therapy, June 2009; 14(2): 34-40.

6. Perez K, Castillo J, Dezube B, Pantanowitz L. HIV- Associated Anaplastic Large Cell Lymphoma. Leukemia and Lymphoma. Mar 2010; 51(3):390-398. 7. Castillo J, Perez K. Role of Ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies. Journal of Blood Medicine. 2010:1 1–8. 8. Castillo J, Winer E, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera J. Prognostic Factors in Chemotherapy-Treated Patients with HIV-Associated Plasmablastic Lymphoma. The Oncologist. March 2010; 15: 293-299. 9. Castillo J, Winer E, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera J. Clinical and pathological differences between HIV-positive and HIV-negative patients with plasmablastic lymphoma. Leukemia and Lymphoma. October 4,2010 [Epub ahead of print] 10. Ng T, Fontaine J, Suntharalingam M, Dipetrillo T, Horiba N, Oldenburg N, Perez K and Safran H. Neoadjuvant Paclitaxel Poliglumex (PPX), Cisplatin and Radiation (RT) for Esophageal Cancer. J Clin Oncol 28:7s, 2010 (suppl; abstr 4085) 11. Castillo J, Milani C, Jabbour M, Perez K, Winer E, Stachurski D. Clinicopathological differences between HIV-positive and HIV-negative plasmablastic lymphoma. Haematologica, June 2010; 95[suppl.2]:607, abstract 1531 12. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Clinical and pathological differences between human immunodeficiency virus- positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma 2010;51(11):2047-2053.

4 13. Perez K, Winer E. Hematology Special Issue: Chronic Lymphocytic Leukemia. Medical Health Rhode Island. 2011 Jan; 94(1): 15-8. 14. Dipetrillo T, Suntharalingam M, Ng T, Fontaine J, Horiba N, Oldenburg N, O’Connor B, Perez K, Birnbaum A, Battafarano R, Burrows W and Safran H. Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial. American Journal of Clinical Oncology. 2011 Feb 3. Epub ahead of print. 15. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. HIV-Negative Plasmablastic Lymphoma: Not In the Mouth. Clin Lymphoma Myeloma Leuk. 2011 April; 11(2): 185-9. 16. Khurshid H, Dipetrillo T, Ng T, Mantripragada K, Birnbaum A, Berz D, Radie-Keane K, Perez K, Constantinou M, Luppe D, Schumacher A, Leonard K, Safran H. A phase I study of Dasatinib with concurrent chemoradiation for stage III Non-Small Cell Lung Cancer. Front Oncol. 2012; 2:56. 17. Khurshid H, Dipetrillo T, Ng T, Mantripagada K, Birnbaum A, Berz D, Radie Keane K, Perez K, Constantinou M, Luppe D, Schumacher A and Safran H. A Phase I Study of Dasatinib With Concurrent Chemoradiation For Stage III Non Small Cell Lung Cancer (NSCLC). American Journal of Clinical Oncology. 2012. In progress. 18. Rich T, Winter K, Safran H, Hoffman J, Erickson B, Anne P, Myerson R, Cline- Burkhardt M, Perez K and Willett C. Weekly Paclitaxel, Gemcitabine and External Irradiation Followed by Randomized Farnesyl Transferase Inhibitor R115777 for Locally Advanced Pancreatic Cancer. OncoTargets and Therapy 2012:5:1-10. 19. Wijnhoven B, Toxopeus E, Vallböhmer D, Knoefel W, Krasna M, Perez K, van Rossum P, Ruurda J, van Hillegersberg R, Schiesser M, Schneider P, and Felix V. New therapeutic strategies for squamous cell cancer and adenocarcinoma. The 11th OESO World Congress Proceedings. Annals of New York Academy of Sciences. 2013 Oct; 1300(1): 213-25.

• Perez K. Trastuzumab: Is there a role for distal esophageal adenocarcinoma, or any potential for treatment for esophageal dysplasia/intra-epithelial neoplasia.

• Perez K. The optimal preoperative treatment prior to surgery is chemotherapy. 20. Safran H, Charpentier K, Kaubisch A, Dubel G, Perez K, Faricy-Anderson K, Miner T, Victor J, Taber A, Bakalarski P, Wingate P, Mantripragada K, Luppe D, Rosati K, Espat J, Isdale D, Eng Y, Martel D, Berz D, Wands J. Lenalidomide for Second-Line Treatment of Advanced Hepatocellular Cancer: A Brown University Oncology Group Phase II Study. American Journal of Clinical Oncology. 2013 July 15. Epub ahead of Print.

21. Perez K, Walsh R, Brilliant K, Noble L, Yakerivich E, Breese V, Jackson C, Chatterjee D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P. Heterogeneity of Colorectal Cancer (CRC) in reference to KRAS proto-oncogene

5 utilizing WAVE technology. Experimental and Molecular Pathology. 2013 Aug; 95(1): 74-82. 22. Cross-Knorr S, Lu S, Guevara S, Brilliant K, Perez K, Pisano C, Resnick M, Chatterjee D. RKIP phosphorylation and STAT3 activation are associated with poor prognosis in colon cancer, and can be inhibited by Oxaliplatin and Camptothecin in vitro. BMC Cancer. 2013, 13:463. BOOKS AND BOOK CHAPTERS: 1. Siegel RS, El-Shami K, Perez K. Hematologic Complications of Pregnancy. Clinical Hematology. Young NS, Gerson SL, High KA. Eds. Elsevier Sciences. Dec 2005: 1456. 2. Perez K, Sikov W. Brain Metastases: Metastases by Gasto-intestinal Tumors. Adult Neuro-Oncology: A Multidisciplinary, Evidence-Based Approach with Case Studies. edited by Drs. Suriya Jeyapalan, Ekkehard Kasper, and Anand Mahadevan. Springer. In Progress. 3. Strenger R, Perez K. Chapter Seven: Special Hematologic Issues in the Pregnant Patient. Medical Management of the Pregnant Patient. K Rosene MD, Eds. Springer. July 2014. 4. Perez K. Primary Myelofibrosis. Ferri’s Clinical Advisor: 5 books in 1. June 17, 2013. 5. Perez K. Monoclonal Gammopathy of Undetermined Significance. Ferri’s Clinical Advisor: 5 books in 1. June 17, 2013.

ORAL PRESENTATIONS

NATIONAL

1. Perez K, Pricolo V, Vrees M, Dipetrillo T, Oldenberg N, Klipfel A, Schecter S, Kinsella T, Roth L, Cataldo T, Shah N, Olszewski A, Isdale D, Safran H, Sikov W. Complete Neoadjuvant Therapy in Rectal Cancer (CONTRE): A Brown University Oncology Research Group Phase II Study. ASCO Gastrointestinal Symposium January 26, 2013. San Francisco, CA. 2. Perez K, Luo X, Brilliant K, Cao L, Noble L, Pantazatos D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P. Proteomic profile of Colorectal Cancer(CRC) Tissue utilizing Imaging Mass Spectrometry. 5th North East Regional IDeA Conference. University of Delaware. August 15, 2013. Wilmington, Delaware. 3. Hwang J, Cohen R, Perez K, Safran H, He A, Giles J, Hu T, Moser B, Turner P, Walgren R, Pilmack E. Interim results of a first-in-human phase 1 study of the oral MET kinase inhibitor, LY2801653, in patients with advanced cancer. 2014 Annual Meeting of the American Association for Cancer Research. Abstract 6558. April 7,2014. San Diego, CA.

6 4. Perez K, Shah N, Pricolo V, Vrees M, Dipetrillo T, Oldenburg N, Klipfel A, Schecter S, Kinsella T, Roth L,Resnick M, Rosati K, Safran H, Sikov W. Complete Neoadjuvant Therapy in Rectal Cancer (CONTRE): A Brown University Oncology Research Group Phase II Study. ASCO Annual meeting. Poster Highlights Session. May 31, 2014. Chicago, IL.

INTERNATIONAL

5. Ng T, Fontaine J, Suntharalingam M, Dipetrillo T, Horiba N, Oldenburg N, Perez K and Safran H. Neoadjuvant Paclitaxel Poliglumex (PPX), Cisplatin and Radiation (RT) for Esophageal Cancer. International Society of Gastrointestinal Oncology. October 1-3, 2009. Philadelphia, PA. 6. New Therapeutic strategies for squamous cell cancer and adenocarcinoma. Moderators: Kandolier D, Ilson DH, Krasna M. Speaker: Perez K • Trastuzumab: Is there a role for distal esophageal adenocarcinoma, or any potential for treatment for esophageal dysplasia/intra-epithelial neoplasia. • The optimal preoperative treatment prior to surgery is chemotherapy. 11th OESO World Congress. Plenary 9. Sept 1-4, 2012. Como, Italy. 7. Safran H, Perez K. Case 2: Stage IIB, Her2-Positive Gastric Cancer What is appropriate adjuvant therapy: chemotherapy alone, chemotherapy plus radiotherapy, or either plus trastuzumab? International Society of Gastrointestinal Oncology (ISGIO). Session 1: Case Presentation/Panel Discussion. September 13, 2012. Washington DC. ABSTRACTS LOCAL/REGIONAL 1. Perez K, Mehegan DeAnzeris K. Male Breast Cancer. May 11, 2005 American College of Physicians Regional Meeting, Providence, RI. 2. Perez K, Gopalkrishnan G, Misra B, Malone C, Tupper T. Big head disease. May 10, 2006 American College of Physicians Regional Meeting, Providence, RI. 3. Giaccotto J, Perez K. Severe Sepsis? Think Again; It might just be liver failure. May 9, 2013 American College of Physicians Regional Meeting, Providence, RI. NATIONAL

1. Perez K, DiSilvestro P, Ilson D, Dizon D, Taneja C. Stage IV small bowel carcinoma mimicking advanced ovarian cancer: case report and review of the literature. February 7-9, 2009 Southeastern Surgical Conference Annual Meeting. Atlanta, GA. 2. Castillo J, Perez K, Milani C, Jabbour M, Stachursky D, Winer E, Quesenberry P. Clinicopathological Differences of HIV-negative and HIV-positive Plasmablastic

7 Lymphoma. Lymphoma & Myeloma Conference. October 22-24, 2009. New York, NY. 3. Ng T, Fontaine J, Suntharalingam M, Dipetrillo T, Horiba N, Oldenburg N, Perez K and Safran H. Neoadjuvant Paclitaxel Poliglumex (PPX), Cisplatin and Radiation (RT) for Esophageal Cancer. ASCO abstract 4085. June 4-8, 2010. Chicago, IL. 4. Safran H, Charpentier K, Kaubisch, A Dubel G, Soares G, Perez K, Wands J, Faricy-Anderson J, Eng Y,Victor J, Espat J, Bakalarski P, Wingate P, Mantripragada K, Berz, D.,Luppe, D. Martel D, Rosati K, and Isdale D. Lenalidomide for second- line treatment of advanced hepatocellular cancer (HCC): A Brown University Oncology Group Phase II Study. ASCO abstract #91419. June 2011. Chicago, IL. 5. Perez K, Pricolo V, Vrees M, Dipetrillo T, Oldenberg N, Klipfel A, Schecter S, Kinsella T, Roth L, Cataldo T, Shah N, Olszewski A, Isdale D, Safran H, Sikov W. Complete Neoadjuvant Therapy in Rectal Cancer (CONTRE): A Brown University Oncology Research Group Phase II Study. ASCO Gastrointestinal Symposium Abstract # 335. January 26, 2013. San Francisco, CA.

6. Panderi (Panteri) I, Cao L, Noble L, Perez K , Pantazatos D. MALDI Imaging Mass Spectrometry (MALDI-IMS) of colon adenocarcinoma formalin-fixed paraffin- embedded tissues. 61st ASMS Conference. Abstract#3079. June 9-13th, 2013. Minneapolis, MN. 7. Perez K, Walsh R, Brilliant K, Noble L, Yakerivich E, Breese V, Jackson C, Chatterjee D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P. Heterogeneity of Colorectal Cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology. ASCO 2013 Annual Meeting Proceedings, a Journal of Clinical Oncology supplement. 8. Fenton MA, Szymanski T, Benson C, Perez K, Phornphutkul C. Breast Cancer Genetic Risk Evaluation and Referral for Assessment. ASCO Quality Care Symposium. November 1-2, 2013. San Diego, California. 9. Safran H, Charpentier K, Perez K, Mantripragada K, Austin T, Nadeem O, Lombardo A, Houlihan L, Fontes-Borts L, Kolberg I, Mitchell K, Rosati K. FOLFOX and nab-paclitaxel (nab-P) for advanced pancreatic cancer: A phase I study. 2014 Gastrointestinal Cancers Symposium. Abstract 258. January 14-16 2014. San Francisco, CA.

INTERNATIONAL 1. Castillo J, Milani C, Jabbour M, Perez K, Winer E, Stachurski D. Clinicopathological differences between HIV-positive and HIV-negative plasmablastic lymphoma. European Hematology Association abstract 1531. June 10-13 2010. Barcelona, Spain.

8 RESEARCH ACTIVITIES 1. Research Tutorial with Professor Robert Siegel; George Washington University School of Medicine- Department of Hematology and Oncology, Washington DC (2003). Individual literature review of hematological and oncologic topics. 2. The Effects of Cancer Diagnosis and Treatment on a Woman’s Sexual Attitudes and Behaviors (2005). Mentor: Mary Anne Fenton, MD. Rhode Island Hospital, Providence, RI. 3. Clinical outcomes in women with colorectal cancers presenting as a pelvic mass to a gender specific oncology clinic (2008). Mentor: Don S. Dizon, MD. Women & Infants’ Hospital, Providence, RI. 4. BrUOG 224: Comprehensive neoadjuvant treatment of rectal cancer with FOLFOX and Radiation. (2009-present). Principal Investigator: William Sikov, MD. Co-Investigator: Kimberly Perez, MD. The Miriam Hospital, Providence, RI. 5. Ofatumumab and Bortezomib for patients with Low-Grade Non-Hodgkin Lymphoma that Relapse after Rituximab. Mentor: Jorge Castillo, MD. The Miriam Hospital, Providence, RI. 6. A Phase I Dose Escalation Study of MLN8237, an Aurora Kinase Inhibitor, in Adult Patients with Nonhematological Malignancies, Followed by a Phase 2 of MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies. Site Principal Investigator: Kimberly Perez, MD. Rhode Island Hospital. Providence, RI. 7. Proteomics of Malignancy. Principal Investigator: Kimberly Perez, MD. Rhode Island Hospital. Providence, RI. 8. Evaluation of gene mutations in cancer tissues utilizing the Wave system 4500 (High performance ion-pairing liquid chromatography (IP-HPLC) Kimberly Perez, MD. Principal Researcher: Douglas Hixson, PhD. Rhode Island Hospital. Providence, RI. 9. Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer. Cancer and Leukemia Group B 80803. Study Chair: Karyn Goodman, MD. Site Principal Investigator: Kimberly Perez, MD. Rhode Island Hospital. Providence, RI. 10. A Phase I Study of Induction Ganitumab and Gemcitbine Followed by Ganitumab, Capecitabine, and 3D-Conformal Radiation Therapy (3D-CRT) with Subsequent Maintenance Therapy For Locally Advanced Pancreatic Cancer. RTOG 1102. Principal Investigator/ Radiation Oncology Chairs: Christopher Crane, MD and Joseph Herman, MD. Medical Oncology Co-Chairs: Howard Safran, MD and Kimberly Perez, MD. Surgical Oncology Co-Chair: Thomas Miner, MD. Radiation Therapy Oncology Group. Philadelphia, PA.

9 11. Risk Assessment of patients with new diagnosis of Gastrointestinal Malignancies. Principal Investigators: Kimberly Perez, MD and Lucia Fontes-Borts, NP. Rhode Island Hospital. Providence, RI. 12. Chart review of patients diagnosed with colorectal cancer with tumor tissue testing for KRAS mutations and the role of WAVE technology in retesting tissue specimens. Principal Investigator: Kimberly Perez, MD. Rhode Island Hospital. Providence, RI. PRESENTATIONS 1. Hematologic Emergencies in Pregnancy. Warren Alpert School of Medicine of Brown University Hematology and Oncology Grand Rounds. April 17, 2008. Providence, RI. 2. Sexual Health and the Medical Oncology Patient. Warren Alpert School of Medicine of Brown University Hematology and Oncology Grand Rounds. December 11, 2008. 3. Systemic Treatment Options for AML in the Elderly. Warren Alpert School of Medicine of Brown University Hematology and Oncology Grand Rounds. October 15, 2009. 4. Oncology Update: 2010 AJCC Staging Updates. Warren Alpert School of Medicine of Brown University Medicine Grand Rounds. August 24, 2010. 5. Oncology Update: 2011 Colorectal Cancer. Warren Alpert School of Medicine of Brown University Medicine Grand Rounds. August 30, 2011. 6. Hemophilia and von Willebrand Disease. Warren Alpert School of Medicine of Brown University Hematology and Oncology Grand Rounds. September 8, 2011. 7. Schwartz Center Rounds: “Dying to be Free: complexities in hospice care”. Rhode Island Hospital. Department of Medicine. Panelists: Jenny Melli MD, Kimberly Perez MD, Noel Javier MD. Moderator Anthony Gallo, MD. January 24, 2012. 8. Update and Panel Discussion on Hereditary Cancer Syndromes. Panelists: Kimberly Perez, MD, Chanika Phornphutkul, MD and Cindy Benson MS. Warren Alpert School of Medicine of Brown University Medicine Grand Rounds. February 14, 2012. 9. Complete Neoadjuvant Therapy in Rectal Cancer and Laboratory Correlatives. Division of Colorectal Surgery. Department of Surgery. Warren Alpert School of Medicine of Brown University February 23, 2012. 10. Colorectal Cancer: Screening, Prevention and Post Treatment Surveillance. Noon Conference. Department of Medicine. Warren Alpert School of Medicine of Brown University Medicine. May 2, 2012 11. Lifespan Survivorship Series: Updates in the Treatment of Colorectal Cancer. Department of Medicine. Division of Oncology. May 9, 2013. 12. Cancer Genetics. Cancer Survivorship. Transition to Health and Well-being. Department of Medicine. Division of Oncology. September 18, 2013.

10 13. Colorectal Cancer Update. Department of Medicine Grand Rounds. Warren Alpert School of Medicine of Brown University Medicine. October 8, 2013. 14. Systemic Therapy in Colorectal Cancer. Department of Surgery. Division of Colorectal Surgery. Warren Alpert School of Medicine of Brown University Medicine. March 6, 2014.

UNIVERSITY TEACHING ROLES 1. Small Group Leader; BioMed Pathophysiology, BIOL3672IMSIV: Hematology Section, The Warren Alpert Medical School of Brown University, January 2010, 2011

2. Invited Speaker; Pre-Clinical Elective on Genetic Diseases. The Warren Alpert Medical School of Brown University. January 4, 2013.

3. Second Reader; Audrey Chang. Senior Honors Thesis. The Warren Alpert Medical School of Brown University. November - May 2013.

4. Second Site Clinical Mentor. Meera Iyengar, MD. Fellow. Rhode Island Hospital. The Warren Alpert Medical School of Brown University. July 2011 – June 2014.

5. Research Mentor. Lucia Fontes-Borts. Nurse Practitioner. Salve Regina University Nurse Practioner Masters Program. Thesis Project. January 2012 - April 2014.

HOSPITAL COMMITTEES 1. Pharmacy and Therapeutics Committee. Member, Rhode Island Hospital. July 2012 – July 2013 2. GastroIntestinal Malignancies Basic Science Forum. Principal Facilitator, Rhode Island Hospital, October 2012 – 3. Molecular Diagnostics in Hereditary Cancer Syndromes Committee. Member, Rhode Island Hospital, March 2012 – 4. Genetics Translational Committee. Medical Oncology Representative, Warren Alpert School of Medicine of Brown University, Rhode Island Hospital and Hasbro Childrens Hospital, October 2012 – 5. Institutional Review Board – Rhode Island Hospital 2. Member. Rhode Island Hospital. June 2014 -

PROFESSIONAL SERVICE 1. Journal Reviewer. American Journal of Clinical Oncology. October 2010 – present. 2. Journal Reviewer. Clinical Advances in Hematology & Oncology. March 2012- present.

11 3. Journal Reviewer. Diseases of the Esophagus. May 2012 – present. 4. Chapter Reviewer. OMICS Group International – eBooks. January 2014 – present. 5. Journal Reviewer. DNA and Cell Biology. January 2014- present. 6. Peer Reviewer. ASCO Educational Book. January 2014 – present.

RESEARCH SUPPORT 1. A Phase I Dose Escalation Study of MLN8237, an Aurora Kinase Inhibitor, in Adult Patients with Nonhematological Malignancies, Followed by a Phase 2 of MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies. Role: Site Principal Investigator October 1, 2010 – August 2013

2. Lifespan Seed Grant: GeoProteomics of Colorectal Cancer Tissue Role: Principal Investigator September 1,2012 – August 31, 2013 3. COBRE Pilot Project Grant: Heterogeneity of Colorectal Cancer Role: Principal Investigator September 1, 2013 – August 31, 2014

4. Protocol I30-MC-JSBA: A Phase 1 Study of LY2801653 in Patients with Advanced Cancer. Role: Site Principal Investigator August 9, 2013 -

PERSONAL INFORMATION 17 Terrace Drive Barrington RI 02806 401-419-6794 Date of Birth: March 5, 1976 Place of Birth: New York, New York Citizenship: United States Spouse: Liam P. Kenny Children: George J. Kenny; Evelyn I. Kenny